학술논문

2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.
Document Type
article
Source
Alzheimer's & dementia : the journal of the Alzheimer's Association. 10(5 Suppl)
Subject
Alzheimer's Association National Plan Milestone Workgroup
Animals
Humans
Alzheimer Disease
Patient Selection
United States Dept. of Health and Human Services
Health Policy
Voluntary Health Agencies
United States
Drug Discovery
Public-Private Sector Partnerships
Translational Medical Research
Biological Ontologies
Biomarkers
Milestones
National Plan to Address Alzheimer's Disease
Policy
Neurodegenerative
Acquired Cognitive Impairment
Neurosciences
Alzheimer's Disease
Prevention
Aging
Dementia
Brain Disorders
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Neurological
Geriatrics
Clinical Sciences
Language
Abstract
With increasing numbers of people with Alzheimer's and other dementias across the globe, many countries have developed national plans to deal with the resulting challenges. In the United States, the National Alzheimer's Project Act, signed into law in 2011, required the creation of such a plan with annual updates thereafter. Pursuant to this, the US Department of Health and Human Services (HHS) released the National Plan to Address Alzheimer's Disease in 2012, including an ambitious research goal of preventing and effectively treating Alzheimer's disease by 2025. To guide investments, activities, and the measurement of progress toward achieving this 2025 goal, in its first annual plan update (2013) HHS also incorporated into the plan a set of short, medium and long-term milestones. HHS further committed to updating these milestones on an ongoing basis to account for progress and setbacks, and emerging opportunities and obstacles. To assist HHS as it updates these milestones, the Alzheimer's Association convened a National Plan Milestone Workgroup consisting of scientific experts representing all areas of Alzheimer's and dementia research. The workgroup evaluated each milestone and made recommendations to ensure that they collectively constitute an adequate work plan for reaching the goal of preventing and effectively treating Alzheimer's by 2025. This report presents these Workgroup recommendations.